NEXTCURE, INC Other Non-Current Liabilities
NEXTCURE, INC (NXTC) had Other Non-Current Liabilities of $455.00 thousand as of 2026-06-30, per its S-4 filed 2026-08-18.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OtherLiabilitiesNoncurrent · last filed 2026-08-18
- 2026-06-30: Other Liabilities, Noncurrent $455.00K.
- 2026-03-31: Other Liabilities, Noncurrent $491.00K.
- 2025-12-31: Other Liabilities, Noncurrent $526.00K.
- 2025-09-30: Other Liabilities, Noncurrent $561.00K.
| Period end | Other Liabilities, Noncurrent |
|---|---|
| 2026-06-30 | $455.00K S-4 · filed 2026-08-18 |
| 2026-03-31 | $491.00K 10-Q · filed 2026-05-07 |
| 2025-12-31 | $526.00K S-4 · filed 2026-08-18 |
| 2025-09-30 | $561.00K 10-Q · filed 2025-11-05 |
| 2025-06-30 | $596.00K 10-Q · filed 2025-08-07 |
| 2025-03-31 | $629.00K 10-Q · filed 2025-05-01 |
| 2024-12-31 | $661.00K S-4 · filed 2026-08-18 |
| 2024-09-30 | $693.00K 10-Q · filed 2024-11-07 |
| 2024-06-30 | $725.00K 10-Q · filed 2024-08-01 |
| 2024-03-31 | $755.00K 10-Q · filed 2024-05-02 |
| 2023-12-31 | $785.00K 10-K · filed 2025-03-06 |
| 2023-09-30 | $815.00K 10-Q · filed 2023-11-02 |
| 2023-06-30 | $843.00K 10-Q · filed 2023-08-03 |
| 2023-03-31 | $872.00K 10-Q · filed 2023-05-04 |
| 2022-12-31 | $899.00K 10-K · filed 2024-03-21 |
| 2021-12-31 | $2.39M 10-K · filed 2023-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |